TRACON Pharmaceuticals, Inc. (TCON)

USD 0.03

(0.0%)

Revenue Summary of TRACON Pharmaceuticals, Inc.

  • TRACON Pharmaceuticals, Inc.'s latest annual revenue in 2023 was 12.04 Million USD , down 0.0% from previous year.
  • TRACON Pharmaceuticals, Inc.'s latest quarterly revenue in 2024 Q2 was 55 Thousand USD , down -45.0% from previous quarter.
  • TRACON Pharmaceuticals, Inc. reported a annual revenue of - USD in annual revenue 2022, down -100.0% from previous year.
  • TRACON Pharmaceuticals, Inc. reported a annual revenue of 346 Thousand USD in annual revenue 2021, down 0.0% from previous year.
  • TRACON Pharmaceuticals, Inc. reported a quarterly revenue of 55 Thousand USD for 2024 Q2, down -45.0% from previous quarter.
  • TRACON Pharmaceuticals, Inc. reported a quarterly revenue of - USD for 2023 Q1, down 0.0% from previous quarter.

Annual Revenue Chart of TRACON Pharmaceuticals, Inc. (2023 - 2012)

Historical Annual Revenue of TRACON Pharmaceuticals, Inc. (2023 - 2012)

Year Revenue Revenue Growth
2023 12.04 Million USD 0.0%
2022 - USD -100.0%
2021 346 Thousand USD 0.0%
2020 - USD 0.0%
2019 - USD -100.0%
2018 3 Million USD -65.73%
2017 8.75 Million USD 153.84%
2016 3.44 Million USD -56.36%
2015 7.9 Million USD 119.68%
2014 3.59 Million USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%

Peer Revenue Comparison of TRACON Pharmaceuticals, Inc.

Name Revenue Revenue Difference
America Great Health 204.3 Thousand USD -5795.511%
Ampio Pharmaceuticals, Inc. - USD -Infinity%
Aridis Pharmaceuticals, Inc. - USD -Infinity%
Biora Therapeutics, Inc. 4000.00 USD -301025.0%
Bio-Path Holdings, Inc. - USD -Infinity%
Better Therapeutics, Inc. - USD -Infinity%
Calithera Biosciences, Inc. - USD -Infinity%
Comera Life Sciences Holdings, Inc. 633.1 Thousand USD -1802.537%
Gene Biotherapeutics, Inc. - USD -Infinity%
eFFECTOR Therapeutics, Inc. - USD -Infinity%
Eloxx Pharmaceuticals, Inc. - USD -Infinity%
Evelo Biosciences, Inc. - USD -Infinity%
Evolutionary Genomics, Inc. - USD -Infinity%
Finch Therapeutics Group, Inc. 107 Thousand USD -11157.009%
Galera Therapeutics, Inc. - USD -Infinity%
Innovation1 Biotech Inc. - USD -Infinity%
Kiromic BioPharma, Inc. - USD -Infinity%
Molecular Templates, Inc. 57.3 Million USD 78.981%
Navidea Biopharmaceuticals, Inc. 65.65 Thousand USD -18246.737%
NexImmune, Inc. - USD -Infinity%
Orgenesis Inc. 530 Thousand USD -2172.642%
Panbela Therapeutics, Inc. - USD -Infinity%
Point of Care Nano-Technology, Inc. - USD -Infinity%
PaxMedica, Inc. Common Stock - USD -Infinity%
Scopus BioPharma Inc. - USD -Infinity%
Sorrento Therapeutics, Inc. 62.83 Million USD 80.832%
Statera Biopharma, Inc. - USD -Infinity%
Trevena, Inc. 3.12 Million USD -285.44%
Vaxxinity, Inc. - USD -Infinity%
Vaccinex, Inc. 570 Thousand USD -2013.158%
Vicapsys Life Sciences, Inc. - USD -Infinity%
Viracta Therapeutics, Inc. - USD -Infinity%
ZIVO Bioscience, Inc. 27.65 Thousand USD -43462.387%